TheraNova has created and spun-out a number of venture capital funded companies, including:


TheraNova’s spin-outs are backed by well-known institutional and strategic investors, including: Boston Scientific, Allergan, Highland Capital, Onset Ventures, Sante, Scientific Health Development, Oakwood, Easton Capital, Third Point Ventures, WS Investment Co. and others.

Additional information on the investment activity of our spin-outs is made available to the public via the SEC website and at


Theranova’s portfolio of incubated companies is supported by a mix of internal capital, grant and angel funding.

For more information on our incubated programs or to learn about upcoming investment opportunities, please email us at

CompanyTechnologyDevelopment StatusFinancing
RespirixNon-invasive alternative to CardioMems for Congestive Heart FailureCompleted Initial In Vivo StudiesVC Seed Funded
PerikineticsIntraperitoneal Artificial Pancreas for Type 1 DiabetesInitial feasibility studyNIH & Private grants
GravitasEnteral Feeding & Monitoring technologyCompleted Initial In Vivo StudiesInternal funding
MimetixWearable biomechanical stimulation technology to prevent OsteoporosisPreparing for initial Human StudiesNIH grant